| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.43 | 0.1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |